CELV (Cellev8 Nutrition) EBIT: $-1.55 Mil (TTM As of Nov. 2015)


CELV Cellev8 Nutrition Inc CELV
30 GF Score
Price $0.05
View Full Analysis

What is Cellev8 Nutrition EBIT?

Cellev8 Nutrition CELV 30 EBIT is $-1.55 Mil as of Nov. 2015. GuruFocus rates CELV with a GF Score™ of 30/100.

Cellev8 Nutrition's earnings before interest and taxes (EBIT) for the six months ended in Nov. 2015 was $-1.55 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2015 was $-1.55 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cellev8 Nutrition's annualized ROC % for the quarter that ended in Nov. 2015 was -39.84%. Cellev8 Nutrition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2015 was -9,706.25%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cellev8 Nutrition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2015 was -8.95%.

Cellev8 Nutrition  (OTCPK:CELV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cellev8 Nutrition's annualized ROC % for the quarter that ended in Nov. 2015 is calculated as:

ROC % (Q: Nov. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2014 ) + Invested Capital (Q: Nov. 2015 ))/ count )
=-1.554 * ( 1 - 0% )/( (3.367 + 4.434)/ 2 )
=-1.554/3.9005
=-39.84 %

where

Invested Capital(Q: Nov. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.392 - 4.569 - ( 0.019 - max(0, 7.915 - 0.371+0.019))
=3.367

Invested Capital(Q: Nov. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.488 - 5.412 - ( 0.035 - max(0, 9.827 - 0.469+0.035))
=4.434

Note: The Operating Income data used here is one times the annual (Nov. 2015) data.

2. Joel Greenblatt's definition of Return on Capital:

Cellev8 Nutrition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2015 is calculated as:

ROC (Joel Greenblatt) %(Q: Nov. 2015 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2014  Q: Nov. 2015
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.553/( ( (0.015 + max(-4.217, 0)) + (0.017 + max(-4.999, 0)) )/ 2 )
=-1.553/( ( 0.015 + 0.017 )/ 2 )
=-1.553/0.016
=-9,706.25 %

where Working Capital is:

Working Capital(Q: Nov. 2014 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.352 + 0) - (4.569 + 0 + 0)
=-4.217

Working Capital(Q: Nov. 2015 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.043 + 0.391 + 0) - (5.412 + 0.022 + -0.0010000000000012)
=-4.999

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Nov. 2015) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cellev8 Nutrition's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Nov. 2015 )
=-1.553/17.350
=-8.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellev8 Nutrition EBIT Related Terms

Cellev8 Nutrition EBIT Historical Data

* Premium members only.

The historical data trend for Cellev8 Nutrition's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellev8 Nutrition EBIT Chart

Cellev8 Nutrition Annual Data
Trend Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
EBIT
Get a 7-Day Free Trial -0.11 -0.14 -0.11 -1.74 -1.55

Cellev8 Nutrition Semi-Annual Data
Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
EBIT Get a 7-Day Free Trial -0.11 -0.14 -0.11 -1.74 -1.55

CELV vs LFVN, MAMA, NATR: EBIT Comparison

For the Packaged Foods subindustry, Cellev8 Nutrition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellev8 Nutrition EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cellev8 Nutrition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cellev8 Nutrition's EV-to-EBIT falls into.


CELV
30GF Score
Cellev8 Nutrition Inc CELV
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellev8 Nutrition EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Nov. 2015 was $-1.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-1.55 Mil mean?
Cellev8 Nutrition (CELV) has a EBIT of $-1.55 Mil as of Nov. 2015. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cellev8 Nutrition.
Is Cellev8 Nutrition's EBIT too high?
Cellev8 Nutrition's current EBIT is $-1.55 Mil. Overall, Cellev8 Nutrition has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cellev8 Nutrition's EBIT compare to LFVN and MAMA?
Cellev8 Nutrition's EBIT of $-1.55 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cellev8 Nutrition. Cellev8 Nutrition's current EBIT is $-1.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellev8 Nutrition stock overvalued right now?
Cellev8 Nutrition (CELV) has a current EBIT of $-1.55 Mil. The current EBIT is $-1.55 Mil. Cellev8 Nutrition's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cellev8 Nutrition (CELV), the current EBIT is $-1.55 Mil as of Nov. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellev8 Nutrition Business Description

Address 3361 Fairline Farms Road, Unit No. 3, Wellington, FL, USA, 33414
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score

Get the complete analysis for CELV

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price